[ TearClear raises $4.5M in Series A ]

TearClear has raised $4.5 million in Series A funding.

Founded in 2015, TearClear is an  eye health technology company uniquely focused on developing a safe and reliable means of delivering preservative-free topical ophthalmic drugs.

The financing will provide sufficient capital to advance development of TearClear’s filter technology, the first and only system to assure the safe delivery of a preservative-free drop from preserved, multi-dose products.

Funding  Series A
Founded  2015
Country  USA
City  Orange County, California
Founder / CEO  Kevin Hershfield
Deal Size  $4.5M
Investors  Bluestem Capital
 Visionary Venture Fund
Previous Investors  /